HR 9679

  • House Bill
  • 117th Congress
  • Introduced in House Dec 22, 2022
  • House
  • Senate
  • Governor

To increase the number of manufacturers registered under the Controlled Substances Act to manufacture cannabis for legitimate research purposes, to authorize health care providers of the Department of Veterans Affairs to provide recommendations to veterans regarding participation in federally approved cannabis clinical trials, and for other purposes.

Abstract

Bill Sponsors (1)

Votes


No votes to display

Actions


Dec 22, 2022

House

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

US Congress

Introduced in House

Bill Text

Bill Text Versions Format
No related documents.

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the US Congress.

If you notice any inconsistencies with these official sources, feel free to file an issue.